Cas 441785-19-9,diethyl (E)-2-1-[1-({[t-butyl(diphenyl)silyl]oxy}methyl)cyclopropyl]-1-propenylphosphonate

441785-19-9

Post Buying Request

Basic information

Product Name: diethyl (E)-2-1-[1-({[t-butyl(diphenyl)silyl]oxy}methyl)cyclopropyl]-1-propenylphosphonate
Synonyms: diethyl (E)-2-1-[1-({[t-butyl(diphenyl)silyl]oxy}methyl)cyclopropyl]-1-propenylphosphonate
CAS NO:441785-19-9
Molecular Formula:
Molecular Weight: 486.664
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: diethyl (E)-2-1-[1-({[t-butyl(diphenyl)silyl]oxy}methyl)cyclopropyl]-1-propenylphosphonate(CAS DataBase Reference)
NIST Chemistry Reference: diethyl (E)-2-1-[1-({[t-butyl(diphenyl)silyl]oxy}methyl)cyclopropyl]-1-propenylphosphonate(441785-19-9)
EPA Substance Registry System: diethyl (E)-2-1-[1-({[t-butyl(diphenyl)silyl]oxy}methyl)cyclopropyl]-1-propenylphosphonate(441785-19-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 441785-19-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

441785-19-9 Suppliers

Recommended suppliers

441785-19-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 441785-19-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,1,7,8 and 5 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 441785-19:
(8*4)+(7*4)+(6*1)+(5*7)+(4*8)+(3*5)+(2*1)+(1*9)=159
159 % 10 = 9
So 441785-19-9 is a valid CAS Registry Number.

441785-19-9Upstream product

441785-19-9Downstream Products

441785-19-9Relevant academic research and scientific papers

NUCLEOSIDE PHOSPHONATE DERIVATIVES USEFUL IN THE TREATMENT OF HIV INFECTIONS

-

Page/Page column 58-59, (2008/06/13)

The present invention relates to a method of treating HIV infections by administering a nucleoside phosphonate derivative represented by formula (I).

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 441785-19-9